BloodTrackR Usability and Concordance Study (BUCS): Evaluating a Smart Home-Based Blood Collection Platform for Remote Monitoring in Rheumatoid Arthritis

Recruiting now

Conditions studied: Rheumatoid Arthritis (RA), Remote Patient Monitoring

In brief

The BloodTrackR Usability and Concordance Study (BUCS) is evaluating a novel home-based blood collection device and companion mobile application for people with rheumatoid arthritis. Participants will use the BloodTrackR device to collect a finger-prick blood sample at home and complete symptom assessments through the app. The study will assess how easy the device and app are to use, whether participants can successfully collect high-quality blood samples outside of a healthcare setting, and how closely the results compare with standard venous blood samples collected by a phlebotomist. Findings will help determine the potential of BloodTrackR to support remote monitoring and reduce reliance on NHS phlebotomy services.

Key facts

Study ID

NCT07660029

Run by

University of Ulster

People needed

20

Starts

2026-06-01

Expected to finish

2026-12-01

Last updated by the study team

2026-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Individuals living with rheumatoid arthritis, who attend community groups or rheumatoid arthritis charity groups
• Aged 18 years or older
• Able to understand written and spoken English
• Individuals who have the capacity to consent
• Access to WiFi and a smartphone/tablet

You may not qualify if…

• Participants <18years
• Participants taking antibiotics/antivirals
• No access to WiFi or a smartphone/tablet

Where it is running

• Personalised Medicine Centre — Londonderry, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.